Detalles de la búsqueda
1.
Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL/MEITL, SPTCL, HSTCL).
Blood
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657272
2.
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
J Oncol Pharm Pract
; 27(4): 1011-1015, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32869692
3.
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
Blood
; 131(4): 397-407, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29141948
4.
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
Lancet Oncol
; 19(2): 257-266, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29276022
5.
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma.
Br J Haematol
; 171(2): 215-226, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26194163
6.
Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma.
Blood
; 122(12): 2104-13, 2013 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23913470
7.
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.
Br J Haematol
; 180(5): 757-760, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27984643
8.
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.
Blood
; 118(20): 5506-16, 2011 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21772049
9.
Idiopathic CD4+ T-lymphocytopaenia with FLT1 mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorder.
BMJ Case Rep
; 16(8)2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37643816
10.
CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma.
Cureus
; 15(9): e44542, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37790017
11.
N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB.
iScience
; 23(12): 101884, 2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33354662
12.
Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Cell Death Dis
; 11(2): 94, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32024820
13.
[Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease]. / Transplantacija autolognih krvotvornih maticnih stanica u bolesnika s relapsom ili refraktornim Hodgkinovim limfomom.
Acta Med Croatica
; 63(3): 215-7, 2009 Jun.
Artículo
en Hr
| MEDLINE | ID: mdl-19827348
14.
New drugs for the treatment of lymphoma.
Hematol Oncol Clin North Am
; 22(5): 1007-35, x, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18954749
15.
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.
Blood Adv
; 7(14): 3760-3763, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36790924
16.
[The disappearance of CD20 positive lymphocytes in the pleural effusion after intrapleural application of rituximab]. / Nestanak CD20 pozitivnih limfocita iz pleuralnog izljeva nakon intrapleuralne primjene rituksimaba u bolesnice s folikularnim limfomom.
Acta Med Croatica
; 61(4): 425-7, 2007 Sep.
Artículo
en Hr
| MEDLINE | ID: mdl-18044481
17.
An Update on the Use of Immunotherapy in the Treatment of Lymphoma.
Curr Hematol Malig Rep
; 12(4): 282-289, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735365
18.
[Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report]. / Mikrocelularni karcinom pluca u bolesnika s hepatosplenicnim t-stanicnim limfomom: prikaz bolesnika.
Lijec Vjesn
; 128(3-4): 76-8, 2006.
Artículo
en Hr
| MEDLINE | ID: mdl-16808095
19.
Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action.
J Cancer Sci Ther
; 5(10): 334-342, 2013 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24466386
20.
Development and characterization of a novel CD19CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomas.
Clin Cancer Res
; 18(14): 3803-11, 2012 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22589392